Zivo Bioscience Price Prediction

ZIVODelisted Stock  USD 1.81  0.01  0.55%   
As of today, the relative strength index (RSI) of Zivo Bioscience's share price is approaching 44. This usually means that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Zivo Bioscience, making its price go up or down.

Oversold Vs Overbought

44

 
Oversold
 
Overbought
The successful prediction of Zivo Bioscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Zivo Bioscience, which may create opportunities for some arbitrage if properly timed.
Using Zivo Bioscience hype-based prediction, you can estimate the value of Zivo Bioscience from the perspective of Zivo Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Zivo Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Zivo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Zivo Bioscience after-hype prediction price

    
  USD 1.81  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zivo Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.721.721.99
Details
Naive
Forecast
LowNextHigh
1.641.641.64
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.731.872.01
Details

Zivo Bioscience After-Hype Price Prediction Density Analysis

As far as predicting the price of Zivo Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zivo Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zivo Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Zivo Bioscience Estimiated After-Hype Price Volatility

In the context of predicting Zivo Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zivo Bioscience's historical news coverage. Zivo Bioscience's after-hype downside and upside margins for the prediction period are 1.81 and 1.81, respectively. We have considered Zivo Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.81
1.81
After-hype Price
1.81
Upside
Zivo Bioscience is very steady at this time. Analysis and calculation of next after-hype price of Zivo Bioscience is based on 3 months time horizon.

Zivo Bioscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Zivo Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zivo Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zivo Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
4 Events / Month
9 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.81
1.81
0.00 
0.00  
Notes

Zivo Bioscience Hype Timeline

Zivo Bioscience is at this time traded for 1.81. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Zivo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Zivo Bioscience is about 0.0%, with the expected price after the next announcement by competition of 1.81. About 25.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 5.33. Zivo Bioscience had not issued any dividends in recent years. The entity had 1:6 split on the 27th of October 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Zivo Bioscience Related Hype Analysis

Having access to credible news sources related to Zivo Bioscience's direct competition is more important than ever and may enhance your ability to predict Zivo Bioscience's future price movements. Getting to know how Zivo Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zivo Bioscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RNXTRenovoRx(0.06)4 per month 3.64  0.08  7.21 (5.17) 40.06 
KTTAPasithea Therapeutics Corp(0.15)5 per month 0.00 (0.04) 8.27 (11.00) 68.44 
QNRXQuoin Pharmaceuticals Ltd 0.01 10 per month 6.71  0.03  17.65 (9.68) 74.46 
ABIOARCA Biopharma(0.38)8 per month 0.00 (0.07) 6.61 (5.89) 123.58 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
ERASErasca Inc 0.03 7 per month 3.67 (0.02) 7.34 (5.38) 17.38 
FBRXForte Biosciences(0.17)4 per month 3.42  0.10  6.65 (6.33) 113.07 
AMTIApplied Molecular Transport(0.02)1 per month 5.70  0.01  11.11 (10.34) 36.60 
SNTISenti Biosciences(0.03)2 per month 0.00 (0.07) 7.35 (7.36) 29.34 
CVKDCadrenal Therapeutics, Common 1.25 11 per month 6.02  0.17  17.85 (7.47) 47.47 
FHTXFoghorn Therapeutics(0.58)10 per month 4.43  0.01  8.50 (6.81) 34.64 
TPSTTempest Therapeutics(0.47)4 per month 0.00 (0.14) 6.38 (8.53) 29.55 
IKNAIkena Oncology(0.05)4 per month 1.39 (0.07) 1.81 (1.74) 13.50 
CBIOCatalyst Biosciences 0.01 2 per month 4.45  0.15  9.76 (8.33) 38.47 

Zivo Bioscience Additional Predictive Modules

Most predictive techniques to examine Zivo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zivo using various technical indicators. When you analyze Zivo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Zivo Bioscience Predictive Indicators

The successful prediction of Zivo Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Zivo Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Zivo Bioscience based on analysis of Zivo Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Zivo Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zivo Bioscience's related companies.

Story Coverage note for Zivo Bioscience

The number of cover stories for Zivo Bioscience depends on current market conditions and Zivo Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zivo Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zivo Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Zivo Bioscience Short Properties

Zivo Bioscience's future price predictability will typically decrease when Zivo Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zivo Bioscience often depends not only on the future outlook of the potential Zivo Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zivo Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 M
Cash And Short Term Investments1.8 M
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation